Navigation Links
Cell Therapeutics, Inc. (CTI) Reports Third Quarter Financial Results and Milestones
Date:10/24/2011

72.4434
E: deramian@ctiseattle.com
www.celltherapeutics.com/media.htm

Investors Contact:
Ed Bell
T: 206.282.7100
Lindsey Jesch Logan
T: 206.272.4347
F: 206.272.4434
E: invest@ctiseattle.com
www.celltherapeutics.com/investors

Cell Therapeutics, Inc.Condensed Consolidated Statements of Operations(In thousands, except for per share amounts)(unaudited)Three Months EndedNine Months EndedSeptember 30,September 30,2011201020112010Revenues:License and contract revenue$
-$
-$
-$
319Total revenues---319Operating expenses:Research and development7,5305,10126,98219,375Selling, general and administrative7,7607,89325,29739,378Total operating expenses15,29012,99452,27958,753Loss from operations(15,290)(12,994)(52,279)(58,434)Other income (expense):Investment and other income (expense), net29(23)54240Interest expense(204)(385)(855)(1,948)Amortization of debt discount and issuance costs(129)(166)(436)(600)Foreign exchange gain (loss)(1,133)1,000(56)(300)Debt conversion expense---(2,031)Net loss before noncontrolling interest(16,727)(12,568)(53,572)(63,073)Noncontrolling interest6546179149Net loss attributable to CTI(16,662)(12,522)(53,393)(62,924)Dividends and deemed dividends on preferred stock(13,023)(3,085)(49,817)(50,519)Net loss attributable to CTI common shareholders$ (29,685)$ (15,607)$
(103,210)$
(113,443)Basic and diluted net loss per common share $
(0.16)$
(0.13)$
(0.62)$
(1.03)Shares used in calculation of basic and diluted184,997118,591165,724109,874Balance Sheet Data:(amounts in thousands)September 30,December 31,20112010(unaudited)Cash and cash equivalents $
45,212$
22,649Working capital19,096(14,165)Total assets62,85053,592Convertible debt12,42922,308Accumulated deficit(1,696,917)(1,576,64
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
2. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
3. Cell Therapeutics, Inc. Announces Reverse Stock Split
4. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
5. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
6. Cell Therapeutics, Inc. (CTI) to Present at Three Upcoming Investor Conferences
7. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes
8. Tobira Therapeutics, Inc. to Present at the 2008 BIO Investor Forum
9. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
10. Cell Therapeutics, Inc. (CTI) to Report 2008 Third Quarter Financial Results on November 7
11. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Calif. , July 31, 2014 Rogne ... San Francisco Bay Area , has acquired a ... of Oxford,s commercialisation company. The potent anti-inflammatory activity of ... at the University of Oxford,s Sir William ... company, which has raised over $1.5 million in seed ...
(Date:7/31/2014)... July 31, 2014 Research and Markets ... Genomics Market 2014-2018" report to their offering. ... is the study of the genetic material or genomes ... strong basis for the discovery and development of diagnostic ... or health conditions. Genomics is supported by three major ...
(Date:7/31/2014)... China , July 31, 2014 ... Irys™System by BGI , the world,s ... comprehensive exploration of human structural variation (SV) and to ... including those where no reference exists. In addition, BioNano ... for multiplexing on the Irys System, enabling significantly higher ...
(Date:7/31/2014)... 31, 2014 Although RNA-Sequencing is ... first transcriptome-wide analyses appearing around 2008, RNA-Sequencing has ... RNA measurement. In the last several years, assays ... work with smaller input amounts, process degraded RNA, ... samples). On the bioinformatics side, there have been ...
Breaking Biology Technology:Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 2Oxford licenses anti-inflammatory peptides to San Francisco Bay Area start-up 3Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4The Evolution of RNA-Sequencing, Upcoming Live Webinar August 22 hosted by Xtalks 2
... Stephen Simes, chief executive,officer of BioSante Pharmaceuticals, ... be featured in an exclusive interview with, http://www.wallst.net ... EDT. The interview,will be posted on http://www.wallst.net ... The interview will cover topics including BioSante,s ...
... MONTEREY, Calif., Sept. 24 Today, the ... that utilize PARI,s,eFlow electronic nebulizer for aerosol ... acquisition of Corus Pharma in,August 2006, this ... a,licensed eFlow is featured prominently in the ...
... WEST BRIDGEWATER, Mass., Sept. 24 Pressure,BioSciences, Inc. ... update on,various corporate activities, including the expansion of ... stock on the Frankfurt Stock Exchange, and,reaffirmation of ... Barocycler instruments. 1) Domestic Sales Force: the ...
Cached Biology Technology:WallSt.net Announces Upcoming Interview with CEO of BioSante Pharmaceuticals 2Pediatric Asthma Programs Featuring PARI Pharma's eFlow Acquired by AstraZeneca 2Pressure BioSciences, Inc. Provides Corporate Update 2Pressure BioSciences, Inc. Provides Corporate Update 3
(Date:7/31/2014)... State University researcher found that bacteria in the Gulf ... the oil released during the Deepwater Horizon spill in ... toxic contaminants. , In two new studies conducted in ... a species of bacteria called Colwellia likely ... xylene compounds that were released as part of the ...
(Date:7/31/2014)... 2014 NXT-ID, Inc., (NXTD: OTCQB) a biometric authentication ... investors and consumers wanting to learn more about ... be on-air today, July 31 st . ... be featured in a segment of NewsWatch, a ... on the History Channel, FYI Network today. ...
(Date:7/30/2014)... the way for a breakthrough that may prevent ... to poisonous chemicalsparticularly those in pesticides and chemical ... issue of the journal ChemBioChem outlines ... commonly used in pesticides and warfare agents. The ... Engineering Associate Professor of Chemical and Biological Engineering ...
Breaking Biology News(10 mins):NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 2NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 3Engineering a protein to prevent brain damage from toxic agents 2
... ARBORWorking beneath the towering oaks and maples on the ... their faculty adviser helped explain an observation that had ... caterpillars. The caterpillars, which defoliate and sometimes kill ... Northeast, are especially fond of oaks, but sugar maple ...
... Escocia, 30 de enero de 2013 Life ... anunció que proveerá una solución de laboratorio íntegra para ... comunes en Libia a raíz de la insurrección de ... durante el régimen de 42 años de Muammar Gaddafi. Se ...
... U.S. Antarctic Program (USAP) and Antarctica New Zealand have jointly ... Antarctic aircraft crash after examination of the plane indicated that ... the wreckage that is largely embedded in snow and ice ... able to recover some equipment from the exposed tail of ...
Cached Biology News:Campus as laboratory: U-M student biologists use Diag trees to help solve gypsy moth mystery 2Campus as laboratory: U-M student biologists use Diag trees to help solve gypsy moth mystery 3Life Technologies ayudará a identificar 20.000 restos humanos encontrados en fosas comunes en Libia 2Life Technologies ayudará a identificar 20.000 restos humanos encontrados en fosas comunes en Libia 3Life Technologies ayudará a identificar 20.000 restos humanos encontrados en fosas comunes en Libia 4US, New Zealand search-and-rescue teams recalled from Antarctic plane crash site 2
Anti-Digoxigenin-AP, Fab fragments; from sheep...
...
... Immunogen: Partially purified chicken ... detects vitamin D receptor (VDR) from ... and fish tissues. This antibody ... glucocorticoid receptors. MA1-710 detects both ...
... AccuPrime™ Pfx DNA Polymerase is ideal ... for downstream applications such as cloning ... provided by a proprietary enzyme preparation ... sp. with proofreading (3'Cut Site5' exonuclease) ...
Biology Products: